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Abstract: To assist with management and interpretation of human metabolomics data, which are
rapidly increasing in quantity and complexity, we need better visualization tools. Using a dataset
of several hundred metabolite measures profiled in a cohort of ~1500 individuals sampled from a
population-based community study, we performed association analyses with eight demographic
and clinical traits and outcomes. We compared frequently used existing graphical approaches
with a novel ‘rain plot’ approach to display the results of these analyses. The ‘rain plot’ combines
features of a raindrop plot and a conventional heatmap to convey results of multiple association
analyses. A rain plot can simultaneously indicate effect size, directionality, and statistical significance
of associations between metabolites and several traits. This approach enables visual comparison
features of all metabolites examined with a given trait. The rain plot extends prior approaches
and offers complementary information for data interpretation. Additional work is needed in data
visualizations for metabolomics to assist investigators in the process of understanding and convey
large-scale analysis results effectively, feasibly, and practically.
Keywords: metabolomics; visualizations; clinical outcomes research; epidemiology
1. Introduction
Advances in metabolomics technologies have enabled the generation of large-scale metabolomics
measures in human studies [1]. Accordingly, newer generation visualization tools are needed to assist
with the analyses and interpretation of these increasingly high-dimensional and complex data sets.
Several resources now offer a variety of techniques for visualizing metabolomics data structure and
exploring the inter-relations between individual and groups of metabolites [2–21].
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The most commonly used methods for visually analyzing and representing associations
between metabolites and outcomes are borrowed from conventional statistics and other biological
fields [2]. Methods such as Manhattan plots, bar and scatter plots, and heatmaps are commonly
used for visualizing information on the association between metabolites and outcomes. However,
creating visualizations that can facilitate the interpretation of multi-level analyses, including information
regarding associations among multiple metabolites and multiple outcomes, continues to pose a special
challenge. We have therefore developed a visualization technique that expands upon existing
approaches to enable the display of results from multiple simultaneous analyses relating metabolites
and clinical phenotypes.
2. Methods
For development of these visualization methods, we used a metabolomics dataset comprising
>500 bioactive lipids assayed by high resolution liquid chromatography-mass spectrometry (LC-MS)
in a subset N = 1447 participants (age 66 ± 9 years, 54% women) of the Framingham Heart Study
offspring cohort. LC-MS was performed according to previously described protocols [22]. In brief,
plasma samples were prepared and analyzed using a Thermo Vanquish UPLC coupled to a high
resolution Thermo QExactive orbitrap mass spectrometer. Metabolites were isolated from plasma using
protein precipitation with organic solvent followed by solid phase extraction. Extracted metabolites
were underwent chromatographic separation using reverse phase chromatography whereby samples
were loaded onto a Phenomenex Kinetex C18 (1.7 µm, 2.1 × 100 mm) column and eluted using
a 7 minute linear gradient starting with water:acetonitrile:acetic acid (70:30:0.1) and ending with
acetonitrile:isopropanol:acetic acid (50:50:0.02). LC was coupled to a high resolution Orbitrap mass
analyzer with electrospray ionization operating in negative ion mode, with full scan data acquisition
across a mass range of 225 to 650 m/z. Thermo .raw data files were converted to 32-bit centroid .mzXML
using Msconvert (Proteowizard software suite), and resulting .mzXML files were analyzed using
Mzmine 2.21, as described [22]. For the present analyses, 16% of analytes had >10% missing values;
we replaced missing values for metabolites with 0.25 x the minimum observed value for that metabolite,
as reported previously [23]. Metabolite variables were then natural logarithmically transformed and
standardized to facilitate cross-metabolite comparisons.
Given the biological importance of lipid metabolites with respect to cardiometabolic disease
traits, we performed multivariable regression analyses to examine the relation of each metabolite
with several clinical traits and outcomes, in the following order: age, female sex, body mass index,
metabolic syndrome [24], prevalent diabetes [25], incident diabetes [25], Framingham Risk Score [26]
as a measure of prevalent cardiovascular risk assessed at examination cycle 8, and incident hard
cardiovascular disease [27] (Figure 1). We displayed the results of these relational analyses using a
variety of techniques, including Manhattan plots (for one outcome at a time, with results ordered by
mass-to-charge [m/z] value), bar and scatter plots (for one outcome at a time, with bars representing
magnitude and directionality of estimates, and scatter dots representing P values), heatmaps (p’s or
beta’s only), rain plot (beta’s, p’s, trends across a panel). We created heatmaps and rainplots with
metabolites both unclustered and clustered based on hierarchical clustering. Details regarding the
coding schema used to develop the rainplot approach and select specific parameters for the type of data
displayed, for a given set of outcomes, are provided at: https://github.com/biodatacore/2017.09-rainplots.
Detailed instructions and the R code for recreating the graphics in this paper is also provided at the
site. All analyses and data visualizations were performed using R v3.4.1.
3. Results
All approaches to visualizing the results of association analyses demonstrated a range in the
degree to which different metabolites were related to the different outcomes of interest. The extent and
type of information conveyed varied across the visualization techniques, as summarized in Table 1 and
detailed below.
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Table 1. Dimension of information offered by different visualization methods.
Visualization Method
Dimension of Information ManhattanPlot
Bar and Scatter
Plots Heatmap Rain Plot
Example Figure 1 andFigure S1 Figure S3
Figure 1 and
Figure S2 Figure 2
Significance of associations with
an outcome X X X
Magnitude of associations with an
outcome X X X
Directionality of associations with
an outcome X X X X
Clustering X X
Significance of associations with
multiple outcomes X X X
Magnitude of associations with
multiple outcomes X
Directionality of associations with
multiple outcomes X
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Figure 1. Visualization of complex metabolomics data. For a set of statistical models (a) performed in a large 
human study, for example, a Manhattan plot (b) can display the degree to which a wide panel of metabolites is 
associated with different outcomes although the magnitude of these associations is not conveyed. Pairing of 
heatmaps can display magnitude as well as directionality and significance for each metabolite association (c), 
although between-metabolite comparisons of associations across all outcomes is not easily discernible. 
For studies that involve multiple staged experiments or statistical models, several options exist for 
visualizing analysis results. Our objective was to overcome limitations associated with discerning clear 
patterns within or between metabolites, especially across multiple plots and outcomes, and with increasing 
data set size. We therefore combined the visualization concepts offered by the conventional heatmap and 
previously reported raindrop plot methods;[28] the latter should not be mistaken for another similarly 
named method used to visualize collections of likelihoods and distributions [29]. As seen in the adapted 
‘rain plot’ shown in Figure 2, directionality and magnitude of estimates for the top 50 metabolites associated 
with the selected outcomes are displayed using a color fill scale and the corresponding significance level is 
represented by size of the circle (i.e., rain ‘droplet’). The metabolites can also be ordered top to bottom by 
smallest to largest P value, mass-to-charge ratio, and by clustering. 
Figure 1. Visualization of complex metabolomics data. For a set of statistical models (a) performed in a
large human study, for example, a Manhattan plot (b) can display the degree to which a wide panel of
metabolites is associated with different outcomes although the magnitude of these associations is not
conveyed. Pairing of heatmaps can display magnitude as well as directionality and significance for
each metabolite association (c), although between-metabolite comparisons of associations across all
outcomes is not easily discernible.
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Figure 2. Rain plots. Results are ordered top to bottom by smallest to largest P value (a), mass-to-charge ratio (b), 
and by clustering (c). 
4. Discussion 
A ‘rain plot’ approach combines the information from paired heatmaps into a single plot that 
emphasizes two types of information: (i) between-outcome comparisons, such as the extent to which most 
metabolites in this panel are associated with certain outcomes (e.g., age, sex) more than others; and, (ii) 
between-metabolite comparisons, such as the extent to which certain metabolites are associated with an 
aggregate measure of clinical cardiovascular disease risk (e.g., Framingham risk score) with or without 
concurrent relations to major component risk factors (e.g., diabetes risk for Metabolites 3 and 4, compared 
to for Metabolites 1 and 2). Between-metabolite comparisons, in particular, can facilitate identification of 
potentially important biological differences underlying the observed results of relating multiple 
metabolites to multiple phenotypes.  
a. b. c.
Figure 2. Rain plots. Results are ordered top to bottom by smallest to largest P value (a), mass-to-charge
ratio (b), and by clustering (c).
Manhattan plots display P values for each model run and highlight statistically significant
associations of all metabolites with each outcome across all the metabolites analyzed and ordered
from left to right along the x axis by mass-to-charge ratio (m/z) (Figure 1 and Figure S1). The marked
significance of metabolite associations with sex as well as BMI, compared with the other outcomes,
is more clearly demonstrated when the results for all outcomes are displayed in a faceted plot
with a shared y axis. Although colored dots can provide information regarding the directionality of
associations, along with corresponding P value, the magnitude of each association is not easily conveyed.
This issue can be addressed using parallel heatmaps, a commonly applied visualization approach for
high-dimensional ‘omics’ data, wherein one plot depicts magnitude of effect and directionality (e.g.,
beta coefficients) while the other depicts corresponding statistical significance (e.g., P value) (Figure 1
and Figure S2). Although such an approach allows for global visualization of data, discerning clear
patterns within or between metabolites can be difficult, especially across multiple heatmap plots and
with increasing data set size. In turn, the bar and scatter plots display both the directionality and
magnitude of associations, along with P values, for each outcome (Figure S3). The extent to which
the same metabolite is positively or negatively associated with different outcomes is not as easily
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discernible. However, the overall trend of generally more positive or more negative associations
observed between a given outcome (e.g., age and Framingham Risk Score) and a large panel of
metabolites is clearly displayed. Exceptions to such trends are also highlighted.
For studies that involve multiple staged experiments or statistical models, several options exist
for visualizing analysis results. Our objective was to overcome limitations associated with discerning
clear patterns within or between metabolites, especially across multiple plots and outcomes, and with
increasing data set size. We therefore combined the visualization concepts offered by the conventional
heatmap and previously reported raindrop plot methods; [28] the latter should not be mistaken for
another similarly named method used to visualize collections of likelihoods and distributions [29].
As seen in the adapted ‘rain plot’ shown in Figure 2, directionality and magnitude of estimates for the
top 50 metabolites associated with the selected outcomes are displayed using a color fill scale and the
corresponding significance level is represented by size of the circle (i.e., rain ‘droplet’). The metabolites
can also be ordered top to bottom by smallest to largest P value, mass-to-charge ratio, and by clustering.
4. Discussion
A ‘rain plot’ approach combines the information from paired heatmaps into a single plot that
emphasizes two types of information: (i) between-outcome comparisons, such as the extent to which
most metabolites in this panel are associated with certain outcomes (e.g., age, sex) more than others;
and, (ii) between-metabolite comparisons, such as the extent to which certain metabolites are associated
with an aggregate measure of clinical cardiovascular disease risk (e.g., Framingham risk score) with or
without concurrent relations to major component risk factors (e.g., diabetes risk for Metabolites 3 and
4, compared to for Metabolites 1 and 2). Between-metabolite comparisons, in particular, can facilitate
identification of potentially important biological differences underlying the observed results of relating
multiple metabolites to multiple phenotypes.
The rain plot visualization emphasizes two types of comparisons: (1) between-outcome results,
and (2) between-metabolite results. For between-outcome comparisons, visually scanning for vertical
patterns of large sized or deeply colored droplets (i.e., droplet ‘streams’) serves to highlight those
outcomes that are the most broadly associated with a given panel of metabolites. As shown in
Figure 2, this particular panel of bioactive lipids appears more globally associated with older age, sex,
and Framingham Risk Score. A special feature of the rain plot is its emphasis on potentially important
between-metabolite comparisons. For instance, certain metabolites (i.e., 20 and 27) are very strongly
associated with sex (Figures 1 and 2). For each of these metabolite rows, a visual scan from left to right
clarifies the relatively lower degrees of association for these metabolites with other outcomes of interest.
The plot also visually clarifies interesting findings between the top-most prioritized metabolites.
For instance, Metabolite 1 is positively associated with older age, male sex, and greater metabolic as
well as cardiovascular disease risk. Conversely, Metabolite 2 is associated with lower metabolic risk,
but is not significantly associated with either age or sex (Figure 2). The plot also highlights a finding for
Metabolite 3 that distinguishes this analyte from Metabolites 1 and 2: while similarly associated with
both greater Framingham Risk Score and risk for incident cardiovascular disease events, Metabolite 3 is
not associated with prevalent or incident diabetes (Figure 2). In effect, Metabolite 3 appears associated
with both prevalent and future cardiovascular risk through a biological pathway that is likely distinct
from diabetes risk. Similar between-metabolite comparisons are possible across the entire plot.
As analytical chemistry methods continue to mature, resulting in larger and more complex
metabolomics data, there is a growing need for ways to visually understand and interpret the relations
of these high-dimensional data with multiple outcomes of interest. Using a dataset of metabolite
measures performed in a population scale cohort, we compared several existing techniques that are
commonly used for visualizing associations between metabolites and clinical outcomes. To improve
these prior methods, we developed and demonstrate the potential utility of a rain plot approach to
maximally render the multiple types of information that can be derived from the observed relationships
between a panel of metabolites and a set of clinical traits and outcomes. We anticipate that this
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approach may be further extended and applied to alternate study designs using different types of
molecular phenotyping data—as part of the ongoing effort to effectively, efficiently, and feasibly convey
the results of large-scale, high-dimensional data analyses [30,31].
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/9/7/128/s1,
Figure S1: Manhattan plots; Figure S2: Parallel heat maps; Figure S3: Bar and scatter plots.
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